Pharma Mar reported EUR44.87M in Gross Profit on Sales for its fiscal quarter ending in June of 2026.





Gross Profit On Sales Change Date
Akebia Therapeutics USD 47.28M 1.7M Dec/2025
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Almirall EUR 429.87M 180.02M Dec/2025
Avita Medical AUD 14.31M 639K Dec/2025
Dianthus Therapeutics USD 463K 179K Mar/2026
Ionis Pharmaceuticals USD 265M 22M Jun/2026
IQVIA Holdings USD 1.44B 368M Jun/2026
Laboratorios Farma EUR 105.28M 177.08M Jun/2025
Moderna USD -566M 792M Mar/2026
Organon & Co USD 783M 71M Mar/2026
Pharma Mar EUR 44.87M 5.63M Jun/2026
Revvity USD 416.87M 29.21M Jun/2026
Tectonic Therapeutic USD 0 0 Mar/2025
Viatris USD 1.57B 193.9M Jun/2026
Xeris Pharmaceuticals USD 72.55M 404K Mar/2026